Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Aashna Uppal, Samiha Rahman, Jonathon R. Campbell, Olivia Oxlade & Dick Menzies. (2021) Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis. PLOS Medicine 18:9, pages e1003712.
Crossref
Crossref
Gesine Meyer-Rath, Craig van Rensburg, Calvin Chiu, Rahma Leuner, Lise Jamieson & Steve Cohen. (2019) The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case. PLOS ONE 14:2, pages e0210497.
Crossref
Crossref
Lara Fairall, Inge Petersen, Babalwa Zani, Naomi Folb, Daniella Georgeu-Pepper, One Selohilwe, Ruwayda Petrus, Ntokozo Mntambo, Arvin Bhana, Carl Lombard, Max Bachmann, Crick Lund, Jill Hanass-Hancock, Daniel Chisholm, Paul McCrone, Sergio Carmona, Thomas Gaziano, Naomi Levitt, Tasneem Kathree & Graham Thornicroft. (2018) Collaborative care for the detection and management of depression among adults receiving antiretroviral therapy in South Africa: study protocol for the CobALT randomised controlled trial. Trials 19:1.
Crossref
Crossref
Gesine Meyer-Rath, Jan Pienaar, Brian Brink, Andrew van Zyl, Debbie Muirhead, Alison Grant, Gavin Churchyard, Charlotte Watts & Peter Vickerman. (2015) The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost–Benefit Analysis. PLOS Medicine 12:9, pages e1001869.
Crossref
Crossref
Gregory Reychler, Gilles Caty, Anne Vincent, Simon Billo & Jean-Cyr Yombi. (2013) Validation of the French Version of the World Health Organization Quality of Life HIV Instrument. PLoS ONE 8:9, pages e73180.
Crossref
Crossref
Rory Leisegang, Gary Maartens, Michael Hislop, John Sargent, Ernest Darkoh & Susan Cleary. (2013) A Novel Markov Model Projecting Costs and Outcomes of Providing Antiretroviral Therapy to Public Patients in Private Practices versus Public Clinics in South Africa. PLoS ONE 8:2, pages e53570.
Crossref
Crossref
Joseph Sempa, Mark Ssennono, Andreas Kuznik, Mohammed Lamorde, Stefanie Sowinski, Aggrey Semeere, Sabine Hermans, Barbara Castelnuovo & Yukari C Manabe. (2012) Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda. BMC Public Health 12:1.
Crossref
Crossref
M. Arantxa Colchero, Yanink N. Caro-Vega, Gilberto Sánchez-González & Sergio Bautista-Arredondo. (2012) A literature review of reporting standards of HIV progression models. AIDS 26:11, pages 1335-1344.
Crossref
Crossref
Gesine Meyer-Rath & Mead Over. (2012) HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions. PLoS Medicine 9:7, pages e1001247.
Crossref
Crossref
Taiwo O. Abimbola & Barbara J. Marston. (2012) The Cost-Effectiveness of Cotrimoxazole in People With Advanced HIV Infection Initiating Antiretroviral Therapy in Sub-Saharan Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes 60:1, pages e8-e14.
Crossref
Crossref
Bruno Ventelou, Yves Arrighi, Robert Greener, Erik Lamontagne, Patrizia Carrieri & Jean-Paul Moatti. (2012) The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model. PLoS ONE 7:4, pages e34101.
Crossref
Crossref
Yoel Lubell, Sarah G. Staedke, Brian M. Greenwood, Moses R. Kamya, Malcolm Molyneux, Paul N. Newton, Hugh Reyburn, Robert W. Snow, Umberto D'Alessandro, Mike English, Nick Day, Peter Kremsner, Arjen Dondorp, Wilfred Mbacham, Grant Dorsey, Seth Owusu-Agyei, Kathryn Maitland, Sanjeev Krishna, Charles Newton, Geoffrey Pasvol, Terrie Taylor, Lorenz von Seidlein, Nicholas J. White, Fred Binka, Anne Mills & Christopher J. M. Whitty. (2011) Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey. PLoS ONE 6:2, pages e17439.
Crossref
Crossref
Prudencia Mweemba, Richard Zeller, Ruth Ludwick, Davina Gosnell & Charles Michelo. (2011) Validation of the World Health Organization Quality of Life HIV Instrument in a Zambian Sample. Journal of the Association of Nurses in AIDS Care 22:1, pages 53-66.
Crossref
Crossref
Ryuichi Komatsu, Eline L Korenromp, Daniel Low-Beer, Catherine Watt, Christopher Dye, Richard W Steketee, Bernard L Nahlen, Rob Lyerla, Jesus M Garcia-Calleja, John Cutler & Bernhard Schwartländer. (2010) Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007. BMC Infectious Diseases 10:1.
Crossref
Crossref
Rory Leisegang, Gary Maartens, Michael Hislop, Leon Regensberg & Susan Cleary. (2010) Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings. BMC Health Services Research 10:S1.
Crossref
Crossref
Steven Simoens. (2010) Health Economics of Antibiotics. Pharmaceuticals 3:5, pages 1348-1359.
Crossref
Crossref
David M Whiley & Theo P Sloots. 2010. Lennette's Laboratory Diagnosis of Viral Infections. Lennette's Laboratory Diagnosis of Viral Infections
19
39
.
M. O. Bachmann, G. Louwagie & L. R. Fairall. 2010. Handbook of Disease Burdens and Quality of Life Measures. Handbook of Disease Burdens and Quality of Life Measures
3223
3243
.
Belkis Aracena-Genao, Jesús Oaxaca Navarro, Hector Lamadrid-Figueroa, Steven Forsythe & Belem Trejo-Valdivia. (2008) Costs and benefits of HAART for patients with HIV in a public hospital in Mexico. AIDS 22:Suppl 1, pages S141-S148.
Crossref
Crossref
Susan M Cleary, Di McIntyre & Andrew M Boulle. (2008) Assessing efficiency and costs of scaling up HIV treatment. AIDS 22:Suppl 1, pages S35-S42.
Crossref
Crossref
Sandrine Loubiere, Kamal Marhoum el Filal, Mustapha Sodqi, Anderson Loundou, Stéphane Luchini, Susan Cleary, Jean-Paul Moatti & Hakima Himmich. (2008) When to Initiate Highly Active Antiretroviral Therapy in Low-Resource Settings: The Moroccan Experience. Antiviral Therapy 13:2, pages 241-252.
Crossref
Crossref
Adamson S Muula, Thabale J Ngulube, Seter Siziya, Cecilia M Makupe, Eric Umar, Hans Walter Prozesky, Charles S Wiysonge & Ronald H Mataya. (2007) Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 7:1.
Crossref
Crossref
Arthi Vijayaraghavan, Molly Bates Efrusy, Peter D Mazonson, Osman Ebrahim, Ian M Sanne & Christopher C Santas. (2007) Cost-Effectiveness of Alternative Strategies for Initiating and Monitoring Highly Active Antiretroviral Therapy in the Developing World. JAIDS Journal of Acquired Immune Deficiency Syndromes 46:1, pages 91-100.
Crossref
Crossref
Phebe K. Lam, Sylvie Naar-KingKathryn Wright. (2007) Social Support and Disclosure as Predictors of Mental Health in HIV-Positive Youth. AIDS Patient Care and STDs 21:1, pages 20-29.
Crossref
Crossref
Viviana Simon, David D Ho & Quarraisha Abdool Karim. (2006) HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. The Lancet 368:9534, pages 489-504.
Crossref
Crossref